The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Nasal drug delivery — Recent developments and future prospects
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biodegradation, biodistribution and toxicity of chitosan
Kean, T., & Thanou, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.004 · Cited by 1,837
Chitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Self-citationChitosan as a novel nasal delivery system for vaccines
Illum, L., Jabbal-Gill, I., Hinchcliffe, M., Fisher, A. N., & Davis, S. S. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00171-5 · Cited by 755
Self-citationChitosan as a Novel Nasal Delivery System for Peptide Drugs
Illum, L., Farraj, N. F., & Davis, S. S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018901302450 · Cited by 629
Self-citationIntranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598
Self-citationThe safety of chitosan as a pharmaceutical excipient
Baldrick, P. (2010) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2009.09.015 · Cited by 569
Effect of Chitosan on Epithelial Cell Tight Junctions
Smith, J., Wood, E., & Dornish, M. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000012150.60180.e3 · Cited by 467
Nasal drug delivery: new developments and strategies
Illum, L. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02529-1 · Cited by 431
Self-citationImmunological activity of chitin and its derivatives
Nishimura, K., Nishimura, S., Nishi, N., Saiki, I., Tokura, S., & Azuma, I. (1984) · Vaccine · doi:10.1016/s0264-410x(98)90039-1 · Cited by 394
Evaluation of the clearance characteristics of bioadhesive systems in humans
Soane, R. J., Frier, M., Perkins, A. C., Jones, N. S., Davis, S. S., & Illum, L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00367-6 · Cited by 360
Self-citationAbsorption Enhancers for Nasal Drug Delivery
Davis, S. S., & Illum, L. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00003 · Cited by 264
Self-citationDelivery of Nerve Growth Factor to the Brain via the Olfactory Pathway
Chen, X.-Q., Fawcett, J. R., Rahman, Y.-E., Ala, T. A., & Frey II, W. H. (1998) · Journal of Alzheimer's Disease · doi:10.3233/jad-1998-1102 · Cited by 247
Nanoparticulate Systems for Nasal Delivery of Drugs: A Real Improvement over Simple Systems?
Illum, L. (2007) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20718 · Cited by 237
Self-citationSlütter, B., Bal, S., Keijzer, C., Mallants, R., Hagenaars, N., Que, I., Kaijzel, E., van Eden, W., Augustijns, P., Löwik, C., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.121 · Cited by 201
Effective nasal influenza vaccine delivery using chitosan
Read, R. C., Naylor, S. C., Potter, C. W., Bond, J., Jabbal-Gill, I., Fisher, A., Illum, L., & Jennings, R. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.021 · Cited by 194
Self-citationClearance characteristics of chitosan based formulations in the sheep nasal cavity
Soane, R. J., Hinchcliffe, M., Davis, S. S., & Illum, L. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00602-0 · Cited by 172
Self-citationIntranasal Delivery of Morphine
Illum, L., Watts, P., Fisher, A. N., Hinchcliffe, M., Norbury, H., Jabbal-Gill, I., Nankervis, R., & Davis, S. S. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.391 · Cited by 160
Self-citationPortenoy, R. K., Burton, A. W., Gabrail, N. Y., & Taylor, D. R. (2010) · Pain · doi:10.1016/j.pain.2010.07.028 · Cited by 155
Marttin, E., Verhoef, J. C., & Merkus, F. W. H. M. (1998) · Journal of drug targeting · doi:10.3109/10611869808997878 · Cited by 147
Nanoparticles as carriers for nasal vaccine delivery
Köping‐Höggård, M., Sánchez, A., & Alonso, M. J. (2005) · Expert Review of Vaccines · doi:10.1586/14760584.4.2.185 · Cited by 143
Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption
Smith, J. M., Dornish, M., & Wood, E. J. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.06.020 · Cited by 138
PecSys:in situgelling system for optimised nasal drug delivery
Watts, P., & Smith, A. M. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902939135 · Cited by 117
Al-Ghananeem, A. M., Saeed, H. M., Florence, R. L., Yokel, R. A., & Malkawi, A. H. (2009) · Journal of drug targeting · doi:10.3109/10611860903483396 · Cited by 116
Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles
Luppi, B., Bigucci, F., Cerchiara, T., & Zecchi, V. (2010) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2010.495981 · Cited by 109
Sintov, A. C., Levy, H. V., & Botner, S. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.004 · Cited by 100
New strategies to improve the intranasal absorption of insulin
Duan, X., & Mao, S. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.03.011 · Cited by 96
Pharmacology and Toxicology of Astrocyte-Neuron Glutamate Transport and Cycling
Sonnewald, U., Qu, H., & Aschner, M. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.1 · Cited by 92
Pilot Study of Nasal Morphine-Chitosan for the Relief of Breakthrough Pain in Patients With Cancer
Pavis, H., Wilcock, A., Edgecombe, J., Carr, D., Manderson, C., Church, A., & Fisher, A. N. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(02)00522-5 · Cited by 79
Intranasal delivery of therapeutic proteins for neurological diseases
Malerba, F., Paoletti, F., Capsoni, S., & Cattaneo, A. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.588204 · Cited by 75
Intravail™: highly effective intranasal delivery of peptide and protein drugs
Maggio, E. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.4.529 · Cited by 66
Fisher, A., Watling, M. I. L., Smith, A., & Knight, A. (2010) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp48138 · Cited by 62
Touítou, E., & Barry, B. W. (2006) · CRC Press eBooks · doi:10.1201/9780849332036 · Cited by 57
Structural requirements of penetratin absorption enhancement efficiency for insulin delivery
Khafagy, E., Morishita, M., Ida, N., Nishio, R., Isowa, K., & Takayama, K. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.01.019 · Cited by 55
Nasal administration of low molecular weight heparin
Arnold, J. J., Ahsan, F., Meezan, E., & Pillion, D. J. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10171 · Cited by 54
Stoker, D. G., Reber, K. R., Waltzman, L. S., Ernst, C. C., Hamilton, D. A., Gawarecki, D., Mermelstein, F. H., McNicol, E. D., Wright, C., & Carr, D. B. (2007) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00300.x · Cited by 51
Leary, A. C., Dowling, M. S., Cussen, K., O’Brien, J., & Stote, R. M. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200613 · Cited by 46
Cheng, Y.-H., Dyer, A. M., Jabbal‐Gill, I., Hinchcliffe, M., Nankervis, R., Smith, A. M., & Watts, P. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.03.014 · Cited by 45
Charlton, S. T., Davis, S. S., & Illum, L. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.01.047 · Cited by 42
Self-citationVed, P. M., & Kim, K. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.040 · Cited by 41
Arnold, J. J., Ahsan, F., Meezan, E., & Pillion, D. J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20123 · Cited by 39
Chain Length-Dependent Effects of Alkylmaltosides on Nasal Absorption of Enoxaparin
Mustafa, F., Yang, T., Khan, M. A., & Ahsan, F. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10579 · Cited by 32
Permeation modulating properties of natural polymers – Effect of molecular weight and mucus
Hagesæther, E. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.046 · Cited by 24
Stote, R. M., Miller, M. J., Marbury, T. C., Shi, L., & Strange, P. (2011) · Journal of Diabetes Science and Technology · doi:10.1177/193229681100500116 · Cited by 22
Uchida, M., Katoh, T., Mori, M., Maeno, T., Ohtake, K., Kobayashi, J., Morimoto, Y., & Natsume, H. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.740 · Cited by 20
Arnold, J. J., Fyrberg, M. D., Meezan, E., & Pillion, D. J. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21977 · Cited by 17
Nasal absorption of mixtures of fast-acting and long-acting insulins
Pillion, D. J., Fyrberg, M. D., & Meezan, E. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.01.013 · Cited by 15
Nasal Delivery of Peptide Drugs
Arnold, J. J., Pillion, D. J., & Meezan, E. (2006) · CRC Press eBooks · doi:10.1201/9781420004816.ch20 · Cited by 6
Cited by
Barua, S., & Mitragotri, S. (2014) · Nano Today · doi:10.1016/j.nantod.2014.04.008 · Cited by 1,257
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
Chitosan in nasal delivery systems for therapeutic drugs
Casettari, L., & Illum, L. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.05.003 · Cited by 444
Self-citationApplication of gellan gum in pharmacy and medicine
Osmałek, T., Froelich, A., & Tasarek, S. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.03.038 · Cited by 421
Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview
Giuliano, E., Paolino, D., Fresta, M., & Cosco, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030159 · Cited by 368
Metadata
- Authors
- Illum, L.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 161
- Issue
- 2
- Pages
- 254-263
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2083537472
- Cited by
- 287
- References
- 48
- FWCI
- 12.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.